Cougar Biotechnology’s Board of Directors Recommends Stockholders Accept Johnson & Johnson’s $43.00 Per Share Cash … (Business Wire via Yahoo! Finance)
LOS ANGELES—-Cougar Biotechnology, Inc. announced today that its board of directors has unanimously agreed to recommend that stockholders tender their shares to Johnson & Johnson at the previously announced price of $43.00 per share.
Original post by Lyle